Test Price
2,800 AED✅ Home Collection Available
BBS4 Gene Bardet-Biedl Syndrome Type 4 Genetic Test in UAE | 2,800 AED | DHA Compliant
Executive Summary & Core Metrics
This advanced genetic test uses Next-Generation Sequencing (NGS) for the BBS4 gene, achieving 99.9% diagnostic sensitivity for confirming Bardet-Biedl syndrome type 4. It includes ISO-certified home collection and post-test counselling.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic post-test clinical guidance in result interpretation by a licensed genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The BBS4 NGS test sequences the entire coding region of the BBS4 gene to identify pathogenic variants linked to Bardet‑Biedl syndrome type 4, a multisystem ciliopathy affecting the kidneys, eyes, and endocrine system.
| Feature | Our Test (Precision / Method / Speed) | Closest Alternative |
|---|---|---|
| Technology | Next‑Generation Sequencing (NGS) – full‑gene with CNV detection | Targeted Sanger sequencing (single amplicon) |
| Variant Detection Rate | 99.9% sensitivity for SNVs, indels, and large deletions/duplications | ~95% for SNVs only; misses structural variants |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks |
| Clinical Utility | Includes genetic counselling and pedigree analysis | Often no dedicated interpretation support |
Physician Insight & Safety Protocols
“As a DHA‑licensed clinical geneticist, I want to reassure you that a positive BBS4 result provides valuable information, but it must be correlated with your clinical history and family pedigree. Always discuss the findings with your treating physician before making any health decisions.” – Lina Osama Zaki Quteineh, DHA No. 9294403
Advisory Notice
Important Advisory: Genetic test results may influence long-term management strategies but do not replace immediate clinical care. Never discontinue prescribed medications without consulting your doctor. This test is not a substitute for emergency treatment.
Safety Exclusion & Emergency Red Flags
Exclusion Criteria & Red Flags
- Exclusion Criteria: This test is not intended for acute emergency diagnosis. Prior genetic counselling and informed consent are required.
- ER Red Flags: Seek immediate medical attention for sudden vision loss, acute kidney failure symptoms, severe respiratory distress, or neurological deterioration – these are medical emergencies unrelated to routine genetic analysis.
Patient FAQ & Clinical Guidance
1. What does the BBS4 NGS test detect, and who should consider it?
The BBS4 NGS identifies pathogenic variants in the entire BBS4 gene, confirming Bardet‑Biedl syndrome type 4. Individuals with a family history or clinical features (polydactyly, obesity, renal anomalies, retinal dystrophy) should consider it.
2. How is the sample collected, and is fasting required?
A simple blood draw or buccal swab is collected by a DHA‑licensed phlebotomist during a home visit; no fasting is needed. The specimen is transported in an ISO‑certified cold‑chain container directly to our genetics lab.
3. When will I receive the results, and what support is available afterwards?
Final results are ready in 3 to 4 weeks. You will receive a detailed report and a tele‑counselling session with a clinical geneticist to interpret findings and plan next steps.
UAE Regulatory & Data Privacy Adherence
This test is performed at DNA Labs UAE, a DHA-licensed facility (License No. 1143) located at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. We adhere to the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning the Use of Information and Communication Technology in Health Fields. Patient data is handled with strict confidentiality and security.
For more information, contact our Data Protection Officer via WhatsApp: +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | BBS4 Gene Bardet-Biedl Syndrome Type 4 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood or Buccal Swab |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV detection |
| ICD-10-CM Code | Q87.8 |
| LOINC Code | 92810-9 |
| DHA Facility License & Laboratory Address | DHA License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians